NPI registry status
Active
2026 NPPES data Allergy Physician NPI 1750302410 MD
Verify on CMS → David Mazza, MD
Allergy Physician in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,017 in Allergy Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
382
Medicare Part D claims · 79 beneficiaries · Allergy Physician avg: 755
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.3/100
▲ 8 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
David Mazza, MD reported a CMS MIPS final score of 91.3/100 - above the 83.1 national average - and filed 382 Medicare Part D claims in 2023.
- 91.3/100
- MIPS score · +8 vs avg
- 382
- Part D claims, 2023
- 66%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
David Mazza, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where David Mazza, MD sits
This provider among allergy physician peers
Across the 175 allergy physician providers who report both Medicare Part D prescribing and a MIPS quality score, David Mazza, MD writes more Part D claims than 25% of them and scores higher on MIPS quality than 69% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one allergy physician peer from a representative sample of 60; the gold marker is David Mazza, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
David Mazza, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about David Mazza, MD?
High performer (top quartile)Primary specialty
Allergy Physician
Medicare Part D claims
382 49% vs specialty avg
MIPS final score
91.3/100 8.2 pts vs avg
Specialty distribution in New York
How Allergy Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
David Mazza, MD's 2023 MIPS final score plotted against the Allergy Physician national average
- MIPS Final Score
- 91.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Allergy Physician) - 91.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
David Mazza, MD appears in the CMS NPPES registry as an Allergy Physician provider holding MD credentials at 7 LEXINGTON AVENUE, New York, NY, 10010, with a listed phone of (212) 677-7170. NPI 1750302410 was issued on 07/21/2006.
Medicare Part D records for calendar year 2023 show 382 prescription claims written by this provider, covering 79 Medicare beneficiaries and totaling roughly $119K in drug spend, split 34% brand-name and 66% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.3/100 for the 2023 performance year (Quality 74.9), compared with the national average of 83.1.
Allergy Physician is a narrow specialty nationwide, with 1,017 enrolled providers across 50 states and an average of 755 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1750302410 |
|---|---|
| Specialty | Allergy Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/21/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.2532
Final Score
Avg: 83.1
74.9203
Quality
91.6794
Promoting Interoperability
Reporting: Alternative Payment Model
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to David Mazza, MD. To verify David Mazza, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
David Mazza, MD - brand share 34.0%
Allergy Physician average
34% brand-name claims vs 66% generic, on 382 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
382
Total Claims
$119K
Total Drug Cost
79
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 525
- Total Day Supply
- 14,951
- Brand vs Generic
- 34% brand / 66% generic
- Brand Drug Cost
- $111K
- Generic Drug Cost
- $8K
- Antibiotic Claims
- 14
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 0.73
- Gender Split
- 70% female / 30% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What David Mazza, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Fluticasone Propio…
Fluticasone Propionate
86 claims
- Montelukast Sodium
Montelukast Sodium
38 claims
- Symbicort
Symbicort
37 claims
- Albuterol Sulfate … 25
Albuterol Sulfate Hfa
25 claims
- Ipratropium Bromide 22
Ipratropium Bromide
22 claims
- Advair Diskus 17
Advair Diskus
17 claims
- Trelegy Ellipta 15
Trelegy Ellipta
15 claims
- Levocetirizine Dih… 14
Levocetirizine Dihydrochloride
14 claims
| Drug | Claims |
|---|---|
| Fluticasone Propionate | 86 |
| Montelukast Sodium | 38 |
| Symbicort Budesonide/Formoterol Fumarate | 37 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 25 |
| Ipratropium Bromide | 22 |
| Advair Diskus Fluticasone Propion/Salmeterol | 17 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 15 |
| Levocetirizine Dihydrochloride | 14 |
| Dupixent Pen Dupilumab | 12 |
| Epinephrine | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy Physician Overview
How David Mazza, MD fits within the Allergy Physician landscape nationally.
1,017
Allergy Physician Providers in US
50
States with Allergy Physician
755
Avg Claims per Provider
David Mazza, MD's 382 claims are below the specialty average of 755.
Nearby Allergy Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Mazza.
Dr. Mohammad Akhtaruzzaman
MD
Canton, NY
Dr. Sherry Arbisser
MD
Jamaica, NY
Dr. Lev Barsky
M.D.
Brooklyn, NY
Dr. Kishan Battu
M.D.
Troy, NY
Dr. Mitchell Boxer
MD
Great Neck, NY
Compare Allergy Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Allergy Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is David Mazza, MD's specialty? ▼
David Mazza, MD specializes in Allergy Physician and practices in New York, New York. Credentials: MD.
How much does David Mazza, MD prescribe under Medicare Part D? ▼
In 2023, David Mazza, MD wrote 382 Medicare Part D claims totaling $119K in drug costs for 79 beneficiaries.
What is David Mazza, MD's Medicare quality score? ▼
David Mazza, MD has a CMS MIPS Final Score of 91.3/100 (Quality: 74.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is David Mazza, MD located? ▼
David Mazza, MD is located at 7 LEXINGTON AVENUE, New York, NY, 10010. Phone: (212) 677-7170.
What is David Mazza, MD's NPI number? ▼
David Mazza, MD's National Provider Identifier (NPI) is 1750302410, issued on 07/21/2006.
Does David Mazza, MD prescribe more brand-name or generic drugs? ▼
David Mazza, MD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $111K in brand drug costs.
How many Allergy Physician providers are there in the US? ▼
There are 1,017 Allergy Physician providers across 50 states in the US. The average Allergy Physician provider writes 755 Medicare Part D claims per year.
What drugs does David Mazza, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, David Mazza, MD's most frequently prescribed drugs include Fluticasone Propionate, Montelukast Sodium, Symbicort. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does David Mazza, MD accept Medicare? ▼
David Mazza, MD appears in CMS Medicare data with 382 Part D claims and 79 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify David Mazza, MD's credentials? ▼
David Mazza, MD's NPI is 1750302410 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.